Study of [S,S]-Reboxetine in Patients With Postherpetic Neuralgia, Who Are Gabapentin Treatment Failures

• Status: Completed
• Trial end date: 2004-10-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine the effectiveness of [S,S]-Reboxetine in the treatment of chronic pain following a shingles infection in patients who are Gabapentin treatment failures.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Pfizer
• Treatments: Gabapentin; Reboxetine

Criteria

Inclusion Criteria:

• Patients must have pain present for more than 3 months after the healing of shingles skin rash.

• Patients at screening must have a score > or = 40 mm on the pain visual analogue scale.

Exclusion Criteria:

• Patients with poor renal function.

• Patients with other severe pain, that may impair the self-assessment of the pain due to shingles.

• Patients with abnormal electrocardiogram.